ARCHIVES

Paraplatin Lengthened TTP In HER2+ Advanced Breast Ca

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: The Walue of Quality of Life Data In Judging Patient Benefit: experts Respond To ODAC

September 3, 1999

Bladder Cancer Epidemiological Study Involves 3,000 Patients

March 2, 1979

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

July 25, 2014

Caryn Lerman Recruited By Univ. Of Pennsylvania.

September 28, 2001

In Brief: Clinton Appoints Breast Cancer coalition’s Fran Visco to President’s Cancer Panel

May 21, 1993

Another Flat Budget For NIH And NCI Despite Strong Bipartisan Support.

January 11, 2008